Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo
Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo Nuvation Bio Announces Acquisition of Japan Rights to Safusidenib from Daiichi Sankyo PR Newswire NEW YORK, April 1, 2026 With acquisition of Japan rights, Nuvation Bio now has global development and...